Back to Search
AMBER KYLE, M.D.
M.D.
Specialist
NPI: 1326123233IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
CMS Specialties
PrimaryDERMATOLOGY
Education
UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF MEDICINE
Class of 1999
Research & Publications (20)
Sound propagation in liquid-filled arterial segments: measurements and model predictions.
PMID 18003027·Annu Int Conf IEEE Eng Med Biol Soc·2007
7-preclinical
Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors.
PMID 17473214·Clin Cancer Res·2007
7-preclinical
Integrating research, surveillance, and practice in environmental public health tracking.
PMID 16835047·Environ Health Perspect·2006
8-other
Integrated assessment of environment and health: America's children and the environment.
PMID 16507470·Environ Health Perspect·2006
8-other
Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture.
PMID 15342419·Cancer Res·2004
8-other
Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent.
PMID 14522888·Cancer Res·2003
7-preclinical
Use of an index to reflect the aggregate burden of long-term exposure to criteria air pollutants in the United States.
PMID 11834467·Environ Health Perspect·2002
6-review
Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging.
PMID 19480975·Int J Radiat Oncol Biol Phys·2009
7-preclinical
Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making.
PMID 19057713·Environ Health Perspect·2008
6-review
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin.
PMID 19010842·Clin Cancer Res·2008
7-preclinical
Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts.
PMID 18381959·Clin Cancer Res·2008
7-preclinical
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels.
PMID 18375822·Mol Cancer Ther·2008
7-preclinical
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK).
PMID 18202010·Mol Cancer Ther·2008
7-preclinical
Computer simulation tool for predicting sound propagation in air-filled tubes with acoustic impedance discontinuities.
PMID 18002427·Annu Int Conf IEEE Eng Med Biol Soc·2007
8-other
Vulnerability as a function of individual and group resources in cumulative risk assessment.
PMID 17520073·Environ Health Perspect·2007
8-other
Urinary bladder infiltration with chronic B-lymphocytic leukemia: two cases with unusual presentation.
PMID 16840221·Leuk Lymphoma·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20911 EARL ST., 310
TORRANCE, CA 90503 - Phone
- (310) 370-9970
Quick Facts
- NPI
- 1326123233
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile